Abdominal Cancer Completed Phase 3 Trials for Bupivacaine (DB00297)

IndicationStatusPhase
DBCOND0036156 (Abdominal Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02927379Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical StressHealth Services Research